Share

February 2022; 12 (1) Research

Use of Transcranial Doppler as a Biomarker of CAR T Cell–Related Neurotoxicity

Kathryn B. Holroyd, Daniel B. Rubin, Sarah LaRose, Andrew Monk, Sarah Nikiforow, Caron Jacobson, Henrikas Vaitkevicius
First published August 9, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001130
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
173

Share

Article Information

vol. 12 no. 1 22-28
DOI: 
https://doi.org/10.1212/CPJ.0000000000001130
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 4, 2020
  • Accepted June 24, 2021
  • First Published August 9, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Kathryn B. Holroyd, MD*,
    2. Daniel B. Rubin, MD, PhD* (drubin4{at}mgh.harvard.edu),
    3. Sarah LaRose, BS (slmichaud{at}bwh.harvard.edu),
    4. Andrew Monk, BS (andrewdmonk{at}gmail.com),
    5. Sarah Nikiforow, MD, PhD (sarah_nikiforow{at}dfci.harvard.edu),
    6. Caron Jacobson, MD (caron_jacobson{at}dfci.harvard.edu) and
    7. Henrikas Vaitkevicius, MD (aa0374{at}gmail.com)
  1. Kathryn B. Holroyd, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Daniel B. Rubin, MD, PhD* (drubin4{at}mgh.harvard.edu),
    3. Scientific Advisory Boards:

    1. (1) Celgene/Bristol-Myers Squibb

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) System and Method for Determining Treatment Outcomes for Neurological Disorders Based on Functional Connectivity Parameters

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Massachusetts General Hospital, Neurologist, 2020-present

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS Grant 5R25NS065743-12, Trainee, 2017-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Sarah LaRose, BS (slmichaud{at}bwh.harvard.edu),
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Andrew Monk, BS (andrewdmonk{at}gmail.com),
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Sarah Nikiforow, MD, PhD (sarah_nikiforow{at}dfci.harvard.edu),
    6. Scientific Advisory Boards:

    1. Ad hoc advisory boards with Kite/Gilead, Novartis and Iovance

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Caron Jacobson, MD (caron_jacobson{at}dfci.harvard.edu) and
    7. Scientific Advisory Boards:

    1. Lonza (SAB)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Kite, Novartis, BMS/Celgene, Lonza, Precision Biosciences, bluebird bio, Epizyme

    Editorial Boards:

    1. Blood Advances - editorial advisory board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Kite, Novartis, BMS/Celgene, Lonza, Nkarta, Precision Biosciences, Abbvie, Bluebird Bio, Epizyme

    Speakers' Bureaus:

    1. AXIS, Clinical Care Options

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Kite, Pfizer

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Henrikas Vaitkevicius, MD (aa0374{at}gmail.com)
    8. Scientific Advisory Boards:

    1. Marinus Pharmaceuticals Inc.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Marinus Pharmaceuticals Inc.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (KBH, SL, AM, HV), Brigham and Women's Hospital, Harvard Medical School, Boston; Department of Neurology (DBR), Massachusetts General Hospital, Harvard Medical School, Boston; and Department of Medical Oncology (SN, CJ), Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  1. Correspondence
    Dr. Holroyd kholroyd{at}partners.org

Article usage

Article usage: August 2021 to October 2023

AbstractFullPdfSource
Aug 2021517011Highwire
Sep 2021263012Highwire
Oct 2021325020Highwire
Nov 2021121015Highwire
Dec 202179012Highwire
Jan 20226808Highwire
Feb 20226365433Highwire
Mar 20221951117Highwire
Apr 202267106Highwire
May 20222725Highwire
Jun 20223743Highwire
Jul 20223003Highwire
Aug 20225552Highwire
Sep 202213042Highwire
Oct 202216995Highwire
Nov 20229023Highwire
Dec 20226832Highwire
Jan 20235112Highwire
Feb 20235331Highwire
Mar 20236324Highwire
Apr 20231522Highwire
May 20233122Highwire
Jun 20232300Highwire
Jul 20235900Highwire
Aug 20231552Highwire
Sep 2023611Highwire
Oct 20231300Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me